PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-55.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-45.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-98.53%
Negative EBIT growth while 5715.T is at 117.02%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-102.86%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-117.37%
Negative net income growth while 5715.T stands at 9311.11%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-117.36%
Negative EPS growth while 5715.T is at 9295.65%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-117.36%
Negative diluted EPS growth while 5715.T is at 9295.65%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
148.41%
Positive 10Y revenue/share CAGR while 5715.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
137.49%
Positive 5Y CAGR while 5715.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
70.80%
Positive 3Y CAGR while 5715.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
100.00%
Positive long-term OCF/share growth while 5715.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.64%
Below 50% of 5715.T's 239.03%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
68.35%
Positive 5Y CAGR while 5715.T is negative. John Neff might view this as a strong mid-term relative advantage.
-112.07%
Negative 3Y CAGR while 5715.T is 24.87%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
336.54%
10Y equity/share CAGR above 1.5x 5715.T's 74.43%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.43%
5Y equity/share CAGR above 1.5x 5715.T's 20.32%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
32.40%
3Y equity/share CAGR above 1.5x 5715.T's 8.22%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.24%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
11.79%
Inventory growth well above 5715.T's 9.83%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-5.75%
Negative asset growth while 5715.T invests at 7.43%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.41%
We have a declining book value while 5715.T shows 6.75%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-6.79%
We’re deleveraging while 5715.T stands at 17.36%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-11.69%
We cut SG&A while 5715.T invests at 18.42%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.